Fuan Pharmaceutical (Group) Co., Ltd., together with its subsidiaries, research and develops, produces, and sells chemical drugs in the People's Republic of China and internationally. It offers APIs; intermediates; and FDFs, such as anti-tumor, specialty drugs, antibiotics, as well as freeze-drying preparation for injection. The company was formerly known as Chongqing Fuan Pharmaceutical (Group) Co., Ltd. and changed its name to Fuan Pharmaceutical (Group) Co., Ltd. in August 2013. The company was founded in 2004 and is headquartered in Chongqing, the People's Republic of China.
Frequently asked questions
What sector does Fuan Pharmaceutical Group Co (300194) operate in?
Fuan Pharmaceutical Group Co belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Fuan Pharmaceutical Group Co (300194) current stock price?
As of the latest data, Fuan Pharmaceutical Group Co stock price is CN¥4.00, with a previous close of CN¥4.00.
What is Fuan Pharmaceutical Group Co (300194) current market capitalization?
Fuan Pharmaceutical Group Co market cap is approximately 4.76 billion.
What is Fuan Pharmaceutical Group Co (300194) Earnings Per Share (EPS)?
The trailing EPS is CN¥0.05.
What is Fuan Pharmaceutical Group Co (300194) Price-to-Earnings (P/E) ratio?
Fuan Pharmaceutical Group Co current P/E ratio is 80.
Does Fuan Pharmaceutical Group Co (300194) pay dividends?
Yes. Fuan Pharmaceutical Group Co pays semiannual dividends with an annualized yield of 2.5% and an estimated annual payout of CN¥0.10 per share.
When is the next ex-dividend date for Fuan Pharmaceutical Group Co (300194)?
The next ex-dividend date is scheduled for November 28, 2026.
What is Fuan Pharmaceutical Group Co (300194) beta (volatility) score?
Fuan Pharmaceutical Group Co has a beta of 0.286, indicating lower volatility than the overall market.
